Business Daily Media

Singapore eDevelopment (SGX:40V) biomedical subsidiary confirms LB2 efficacy against Ebola

  • Written by ACN Newswire

Singapore eDevelopment (SGX:40V) biomedical subsidiary confirms LB2 efficacy against Ebola

SINGAPORE, Mar 1, 2018 - (ACN Newswire) - Singapore eDevelopment (SGX: 40V; SeD) is pleased to announce biomedical subsidiary Global BioLife, Inc. has completed the initial Zaire Ebola research portion for the study of new anti-viral drug LB2, part of its new universal therapeutic drug platform, Linebacker, which is designed to combat a range of...

Start your own business with Shopify


The Rise and Rise of Cyber Threats: Why Due Diligence is More Important Than Ever

It’s no surprise that Australia, like many countries, is facing a rise in cyber security threats with the latest Australian Cyber Security Center ...

Business Training

Mastering English from Home with The Benefits and Strategies of Online English Tutoring

Online English tutoring has become an increasingly popular way to improve one's language skills from the comfort of their own home. With the help of k...

Business Training

Why Carports are a Smart Addition for Australian Homes

Car enthusiasts and car fanatics love their vehicles a little too much. Australian weather is an enemy for vehicles since there could be rain show...

Property

3 Simple Ways to Earn More Dog Walking Clientele

A dog walking business can be very lucrative. Pet owners outside the house for significant periods lean on this service to care for their furry fr...

Business Training

Price Analysis of Pacific Palisades Houses

Pacific Palisades is a highly sought-after neighborhood located in the Westside of Los Angeles, California. With its pristine beaches, lush parks...

Property

What Is A Property Investment Fund?

A property investment fund is a financial vehicle that allows individuals to invest in real estate properties through pooled resources. These fund...

Property